Combined with the promoting effect of TGF-β1 on EMT in SSc-ILD model mice, it is indicated that PESV may achieve the inhibition of EMT by regulating the TGF-β1 pathway, thereby alleviating pulmonary inflammation and interstitial fibrosis in mice. Here, TGFB1 is linked to systemic sclerosis.